Perioperativer Umgang mit immunsuppressiver Therapie

  title={Perioperativer Umgang mit immunsuppressiver Therapie},
  author={Johanna Wagner and Verena Luber and J. F. Lock and Ulrich Andreas Dietz and Sven Lichthardt and Niels Matthes and Katica Krajinovic and Christoph T. Germer and Stefan Knop and Armin Wiegering},
  journal={Der Chirurg},
ZusammenfassungPro Jahr werden in Deutschland ca. 16 Mio. operative Eingriffe durchgeführt. Eine ganze Reihe von Patienten hat eine Autoimmunerkrankung, z. B. rheumatoide Arthritis, Psoriasis, chronisch-entzündliche Darmerkrankungen, die einer Therapie bedarf. Hier werden vor allem Immunsuppressiva eingesetzt. Im klinischen Alltag ist der operativ tätige Arzt mit der Frage konfrontiert, ob diese perioperativ fortgeführt werden können oder pausiert werden sollten und wenn ja, mit welchem Risiko… 
2 Citations
Immunsuppressive Therapie und Knochenheilung
Hospital admission should preoperatively evaluate the possibility of interrupting immunosuppressive medications for the perioperative treatment period without risking a relapse of the underlying disease and which surgical approach should be individually selected for the patient.
High-Risk Perioperative Medications in the Chinese Elderly Population
The validity of the HRPOMs list in the perioperative medication review for the elderly is shown and may induce further research to reveal the impact of HRPoms upon the surgical outcomes of the elderly.


Severe steroid-unresponsive ulcerative colitis
Given the absence of postoperative mortality and a low overall complication rate, restorative proctocolectomy can safely be perofrmed in patients who fail rescue treatment with a dose of 2 mg/kg of cyclosporin for steroid-refractory ulcerative colitis.
Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.
Inflammatory bowel disease: perioperative pharmacological considerations.
This review surveys the findings of the selected articles and presents guidelines and resources for perioperative medication management for patients with inflammatory bowel disease undergoing surgery.
Patterns and Associated Risk of Perioperative Use of Anti-Tumor Necrosis Factor in Patients with Rheumatoid Arthritis Undergoing Total Knee Replacement
There was a low risk of infection and perioperative adverse events in patients with RA receiving anti-TNF therapy who were undergoing TKR, raising the question whether it is necessary to stop anti-tumor necrosis factor for a long period prior to surgery.
Thiopurine Therapy Is Associated with Postoperative Intra-Abdominal Septic Complications in Abdominal Surgery for Crohn’s Disease
Thiopurine therapy is associated with postoperative intra-abdominal septic complications after abdominal surgery for Crohn’s disease, and the increased risk was related to the number of identified risk factors.
Preoperative Steroid Use and Risk of Postoperative Complications in Patients With Inflammatory Bowel Disease Undergoing Abdominal Surgery
There is an increased risk of total as well as infectious complications following the use of steroids in patients with IBD.